Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tushar Deshchougule A"'
Autor:
Usha Bughani, Arindam Saha, Anshu Kuriakose, Reshmi Nair, Ravindra B Sadashivarao, Rasika Venkataraman, Swati Patel, Anuja Tushar Deshchougule, Kumar S Satish, Enrique Montero, Harish V Pai, Dinesh V Palanivelu, Ramakrishnan Melarkode, Pradip Nair
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0192335 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0180088.].
Externí odkaz:
https://doaj.org/article/1c22fa488f94401a8e39af0a7fad63fe
Autor:
Usha Bughani, Arindam Saha, Anshu Kuriakose, Reshmi Nair, Ravindra B Sadashivarao, Rasika Venkataraman, Swati Patel, Anuja Tushar Deshchougule, Satish Kumar S, Enrique Montero, Harish V Pai, Dinesh V Palanivelu, Ramakrishnan Melarkode, Pradip Nair
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180088 (2017)
CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases. We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production
Externí odkaz:
https://doaj.org/article/c65b7916659142f78e52a699d7aa8db6
Autor:
Arindam Saha, S Satish Kumar, Pradip Nair, Swati Patel, Ravindra B. Sadashivarao, Anuja Tushar Deshchougule, H. Pai, Ramakrishnan Melarkode, Usha Bughani, Dinesh V. Palanivelu, Reshmi Nair, Enrique Montero, Rasika Venkataraman, Anshu Kuriakose
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0180088 (2017)
PLoS ONE, Vol 12, Iss 7, p e0180088 (2017)
CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases. We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a3ced6ad04b86d63417235f3ddc057
https://pubmed.ncbi.nlm.nih.gov/29381749
https://pubmed.ncbi.nlm.nih.gov/29381749
Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab
Autor:
Pradip Nair, H. Pai, Ravindra B. Sadashivarao, Swati Patel, Anuja Tushar Deshchougule, Reshmi Nair, Arindam Saha, Kumar Satish, Enrique Montero, Dinesh V. Palanivelu, Ramakrishnan Melarkode, Anshu Kuriakose, Usha Bughani, Rasika Venkataraman
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0192335 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0180088.].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcec8c3383623999da52a3920c66ebbc
https://doi.org/10.1371/journal.pone.0192335
https://doi.org/10.1371/journal.pone.0192335
Autor:
Bughani, Usha, Saha, Arindam, Kuriakose, Anshu, Nair, Reshmi, Sadashivarao, Ravindra B., Venkataraman, Rasika, Patel, Swati, Tushar Deshchougule, Anuja, Satish, Kumar S., Montero, Enrique, Pai, Harish V., Palanivelu, Dinesh V., Melarkode, Ramakrishnan, Nair, Pradip
Publikováno v:
PLoS ONE; 1/30/2018, Vol. 13 Issue 1, p1-1, 1p